Atlas Trials

A Single Blinded Study on the Effect of Saccharomyces Boulardii CNCM I-745 on Growth and Development in Preterm Infants

Clinical trial NCT02310425 · COMPLETED

Trial details

NCT number
NCT02310425
Sponsor
Lingfen Xu, MD
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infant, Premature, Diseases
Start date
2013-03-01
Primary completion
2013-07-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.